维普中文期刊产品整合服务
37篇 您的检索式:作者名="David R Anderson"
    题名 作者 年代 出处 被引量
1Protective role of PI3-kinase/Akt/eNOS signaling in mechanical stress through inhibition of p38 mitogenactivated protein kinase in mouse lung显示文摘Xin-qi PENG Mahendra DAMARLA Jarrett SKIRBALL Stephanie NONAS Xiao-ying WANG Eugenia J HAN Emile J HASAN Xuan CAO Adel BOUEIZ Rachel DAMICO Rubin M TUDER Alfred M SClUTO Dana R ANDERSON Joe GNGARCIA David A KASS Paul M HASSOUN Jun-tian ZHANG 2010Acta Pharmacologica Sinica2010,31,2:6
2Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial显示文摘Paul Y Kwo Eric J Lawitz Jonathan McCone Eugene R Schiff John M Vierling David Pound Mitchell N Davis Joseph S Galati Stuart C Gordon Natarajan Ravendhran Lorenzo Rossaro Frank H Anderson Ira M Jacobson Raymond Rubin Kenneth Koury Lisa D Pedicone Clifford 2010The Lancet2010,,9742:3
3Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial显示文摘David N Krag Stewart J Anderson Thomas B Julian Ann M Brown Seth P Harlow Joseph P Costantino Takamaru Ashikaga Donald L Weaver Eleftherios P Mamounas Lynne M Jalovec Thomas G Frazier R Dirk Noyes André Robidoux Hugh MC Scarth Norman Wolmark 2010Lancet Oncology2010,,10:3
4Sexually dimorphic expression of multiple doublesex -related genes in the embryonic mouse gonad显示文摘Shinseog Kim Jae R Kettlewell Robert C Anderson Vivian J Bardwell David Zarkower 2002Gene Expression Patterns2002,,1:2
5Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial显示文摘David N Krag Stewart J Anderson Thomas B Julian Ann M Brown Seth P Harlow Takamaru Ashikaga Donald L Weaver Barbara J Miller Lynne M Jalovec Thomas G Frazier R Dirk Noyes André Robidoux Hugh MC Scarth Denise M Mammolito David R McCready Eleftherios P Mamo 2007Lancet Oncology2007,,10:2
6Review of selenite cataract显示文摘SHEARER T R DAVID L L ANDERSON R S 1992Curr Eye Res1992,11,:1
7Visualizing neuromodulation in vivo:TANGO-mapping of dopamine signaling reveals appetite control of sugar sensing显示文摘Inagaki Hidehiko K Ben-Tabou de-Leon S Wong AM Jagadish S Ishimoto H Barnea G Kitamoto T Axel R Anderson David J 0,,03:1
8Foodborne Campylobacter: Infections, Metabolism, Pathogenesis and Reservoirs显示文摘Epps Sharon V R Harvey Roger B Hume Michael E Phillips Timothy D Anderson Robin C Nisbet David J 2013International Journal of Environmental Research and Public Health2013,,12:1
9Effect of high-dose simvastatin on brain atrophy and disability in secondary progressive multiple sclerosis (MS-STAT): a randomised, placebo-controlled, phase 2 trial显示文摘Jeremy Chataway Nadine Schuerer Ali Alsanousi Dennis Chan David MacManus Kelvin Hunter Val Anderson Charles R M Bangham Shona Clegg Casper Nielsen Nick C Fox David Wilkie Jennifer M Nicholas Virginia L Calder John Greenwood Chris Frost Richard Nicholas 2014The Lancet2014,,:1
10Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial显示文摘Paul Y Kwo Eric J Lawitz Jonathan McCone Eugene R Schiff John M Vierling David Pound Mitchell N Davis Joseph S Galati Stuart C Gordon Natarajan Ravendhran Lorenzo Rossaro Frank H Anderson Ira M Jacobson Raymond Rubin Kenneth Koury Lisa D Pedicone Clifford 2010The Lancet2010,,9742:1
11Depth Profile Studies Using Laser-Induced Plasma Emission Spectrometry显示文摘David R Anderson Cameron W 1995Applied Spectroscopy1995,49,6:1
12Sources of dioxins in the United Kingdom: the steel industry and other sources 显示文摘David R Anderson Raymond Fisher 2002Chemosphere2002,,46:1
13Randomized controlled trial of recombinant alpha-2a-interferon for chronic hepatitis C显示文摘David D. Douglas MD Dr. Jorge Rakela MD Hsiang Ju Lin DSc F. Blaine Hollinger MD Howard F. Taswell MD Albert J. Czaja MD John B. Gross MD Monte L. Anderson MD Kevin Parent MD C. Richard Fleming MD John R. Cangemi MD Peter C. O’Brien PhD Pauline E. Powis R 1993Digestive Diseases and Sciences1993,,4:1
14PCDD/F and 'Dioxin-like' PCB emissions from iron ore sintering plants in the UK 显示文摘Aries Eric Anderson David R Fisher Raymond 2006Chemosphere2006,65,:1
15Sources of Dioxins in the United Kingdom: the Steel Industry and other source 显示文摘ANDERSON David R Fisher Raymond 2002Chemosphere2002,,46:1
16Whitnall's sling for poor func2tion ptosis显示文摘Richard L Anderson RL David R 1990Arch Ophthalmol1990,108,:1
17Protein Identification With a Single Accurate Mass of a Cysteine-Containing Peptideand Constrained Database Searching 显示文摘Goodlett David R Bruce James E Anderson Gordon A 2000Anal Chem2000,72,11:1
18Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial显示文摘Paul Y Kwo Eric J Lawitz Jonathan McCone Eugene R Schiff John M Vierling David Pound Mitchell N Davis Joseph S Galati Stuart C Gordon Natarajan Ravendhran Lorenzo Rossaro Frank H Anderson Ira M Jacobson Raymond Rubin Kenneth Koury Lisa D Pedicone Clifford 2010The Lancet2010,,9742:1
19Sources of dioxins in the United Kingdom:the steel industry and other sources显示文摘David R Anderson and Raymond Fisher 2002Chemosphere2002,,46:1
20Ecotourism demand and differential pricing of national park access in Costa Rica显示文摘Lisa C Chase David R Lee William D Schulze and Deborah J Anderson 1998Land Economics1998,74,4:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费